NCT02574403View on ClinicalTrials.gov

Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 3, 2019

Study Completion Date

December 3, 2019

Conditions

Atypical Hemolytic Uremic Syndrome

Interventions

DRUG

eculizumab

eculizumab discontinuation

Trial Locations (22)

Unknown

CHU Amiens, Amiens

CHU Bordeaux, Bordeaux

CHU Caen, Caen

CH métropole Savoie, Chambéry

CH Dijon, Dijon

Ch Le Mans, Le Mans

CHRU Lille, Lille

CHU lyon, Lyon

AP-HM, Marseille

CH Metz Thionville, Metz

CHU Montpellier, Montpellier

CHU Nantes, Nantes

CHU Nice, Nice

BICHAT, Paris

Hopital Necker, Paris

Hopital Tenon, Paris

Hôpital Européen Georges Pompidou, Paris

CHU Rouen, Rouen

CH Alpes Léman, Sallanches

CHU Strasbourg, Strasbourg

Hopital FOCH, Suresnes

CHU toulouse, Toulouse

All Listed Sponsors

lead

Nantes University Hospital

OTHER

NCT02574403 - Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS | Biotech Hunter | Biotech Hunter